Tags:BiopharmaBioTechHuman
Biotechnology company developing novel oncology therapeutics based on a deep understanding of the human immune response
Location: United States, Redwood City
Total raised: $222M

Investors 1

Funding Rounds 4

DateSeriesAmountInvestorsDeal News
12.09.2018Series C$125M--
17.08.2017Series B$35M--
04.11.2015Series A$56M--
25.09.2012-$6M--

Mentions in press and media 10

DateTitleDescriptionCategoryAuthorSource
29.07.2021Atreca : P...Completed dose escalation port...--marketscre...
16.09.2018Atreca Rai...Atreca, Inc., a Redwood City, ...USA-finsmes.co...
14.09.2018Term Sheet...BORING IS THE NEW BLACK Good ...--fortune.co...
12.09.2018Atreca rai...The unnamed fund also co-led A...--medcitynew...
20.08.2017Wellington...REDWOOD CITY, Calif.--(BUSINES...--citybizlis...
17.08.2017Term Sheet...CROWDFUNDING, 40 UNDER 40, FEE...--fortune.co...
17.08.2017Atreca Com...Atreca, Inc., a Redwood City, ...USA-finsmes.co...
04.11.2015Atreca Com...Atreca, Inc., a Redwood City, ...USA-finsmes.co...
04.11.2015Daily fund...Atreca completed $56M funding;...-Mitos Suso...vator.tv/n...
25.09.2012Atreca Rec...Atreca, Inc., a San Carlos, Ca...funding U...-finsmes.co...